Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in RNAC — Cartesian Therapeutics, Inc.

CIK 1107261 HOUSTON, TX
Back to RNAC Full portfolio

Position in RNAC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$338,650
+$184,900 QoQ
Shares Held
32,500
+30.0% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#29
of 95 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. RNAC ranks #56 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in RNAC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $338,650 32,500
2026-03-31 $153,750 25,000
2025-12-31 $180,250 25,000
2025-09-30 $255,500 25,000
2024-09-30 $164,311 10,193
2024-06-30 $275,312 10,193
2024-03-31 $198,769 305,800
2023-12-31 $314,046 455,800
2023-09-30 $483,147 455,800
2023-06-30 $510,495 455,800
2023-03-31 $604,649 435,000
2022-09-30 $31,487 19,200
2020-03-31 $477,420 198,100